Resistance in the Genes: Why Popular Obesity Drugs Don’t Work for Everyone
GLP-1 receptor agonists like Wegovy and Mounjaro have fundamentally reshaped the treatment of diabetes and obesity.
Search results for "obesity diabetes treatment"
“Lose Belly Fat Now”: Could Your Waistline Be a Warning Sign for Parkinson’s?
Elevated blood pressure, an expanding waistline, and unexplained bouts of depression often occur together.
Erectile Dysfunction on the Rise Among Men in Their 20s and 30s
“Physically, everything seems fine—so why isn’t it working?” This concern is increasingly common among men in their...
Beyond the Badge: Why a 'Team' Matters More Than a Certification in Severe Obesity Surgery
More than 10 years have passed since the tragic death of the late singer Shin Hae-chul.
A Major Paradigm Shift in Cholesterol Management: Earlier Testing, 30-Year Risk Predictions
Heart disease often appears as a sudden crisis, but it is typically the result of risks that have quietly accumulated...
HK inno.N’s ‘Ecnoglutide’: Can a Late Entrant’s “Hidden Card” Reshape the Obesity Market?
HK inno.N is fast-tracking the South Korean launch of ecnoglutide, a GLP-1 receptor agonist licensed from China’s...
The Hidden Link Between Blood Sugar Spikes and Belly Fat
Obesity researchers have shifted their focus from general body weight to a more specific and dangerous culprit:...
GLP-1 Drugs and Bone Health: Studies Highlight Fracture Risks in Elderly Patients
The GLP-1 receptor agonist class of drugs, widely used for the treatment of obesity and type 2 diabetes, has...
The Unexpected Heart Benefits of Weight Loss Injections: Reducing Complications After Heart Attack
New research indicates that the class of drugs used in popular weight loss injections may do more than shed pounds;...
The Growing Link Between Diet and Pancreatic and Colorectal Cancers
In recent years, medical professionals have observed a sharp decline in the pancreatic and colorectal health of the...